Related Experiment Video

Updated: Apr 28, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

8.0K

The new concepts on overcoming drug resistance in lung cancer

Weisan Zhang1, Ping Lei1, Xifeng Dong2

  • 1Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Drug Design, Development and Therapy
|June 20, 2014
PubMed

Insights

Lung cancer drug resistance is a major challenge, with about half of patients developing resistance to epidermal growth factor receptor-tyrosine kinase inhibitors. This review explores four strategies to overcome resistance and prolong lung cancer treatment efficacy.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Lung cancer remains a leading cause of cancer-related mortality globally.
  • Current first-line treatments involve chemotherapy, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), and radiotherapy.
  • Acquired drug resistance significantly hinders patient prognosis, with approximately 50% of patients on EGFR-TKI therapy developing resistance.

Purpose of the Study:

  • To review and discuss emerging strategies for overcoming acquired drug resistance in lung cancer.
  • To explore methods that can prolong the efficacy of first-line lung cancer therapies.
  • To provide insights into current research addressing a critical obstacle in lung cancer treatment.

Main Methods:

  • Literature review of current research on lung cancer drug resistance mechanisms.
  • Analysis of developed strategies aimed at overcoming resistance to EGFR-TKIs and other therapies.
  • Synthesis of evidence regarding the potential of novel approaches to enhance treatment outcomes.

Main Results:

  • Drug resistance is a complex, multifactorial issue in lung cancer treatment.
  • Several promising strategies are under development to combat resistance.
  • These strategies aim to restore sensitivity to existing therapies or introduce alternative treatment modalities.

Conclusions:

  • Overcoming acquired drug resistance is crucial for improving lung cancer patient survival.
  • The discussed strategies offer potential pathways to enhance the effectiveness and durability of lung cancer treatments.
  • Further research is needed to fully elucidate resistance mechanisms and optimize therapeutic interventions.
Keywords:
ALK receptors cancer stem cellEGFR-TKIbiotherapychemotherapymolecular biologypharmacologytarget therapy

More Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

7.6K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

12.8K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K